✦ LIBER ✦

Biomarkers and Surrogate End Points for Fit-for-Purpose Development and Regulatory Evaluation of New Drugs

✍ Scribed by Wagner, J A; Williams, S A; Webster, C J

Book ID: 110019903
Publisher: Nature Publishing Group
Year: 2007
Tongue: English
Weight: 74 KB
Volume: 81
Category: Article
ISSN: 0009-9236
DOI: 10.1038/sj.clpt.6100017

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The Value, Qualification, and Regulatory

The Value, Qualification, and Regulatory Use of Surrogate End Points in Drug Development

✍ Lathia, CD; Amakye, D; Dai, W; Girman, C; Madani, S; Mayne, J; MacCarthy, P; Per 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 225 KB

Surrogate endpoints in chemoprevention o

Surrogate endpoints in chemoprevention of breast cancer: Guidelines for evaluation of new biomarkers

✍ Susan G. Hilsenbeck; Gary M. Clark 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 579 KB

Assessing proliferation, cell-cycle arre

Assessing proliferation, cell-cycle arrest and apoptotic end points in human buccal punch biopsies for use as pharmacodynamic biomarkers in drug development

✍ Camidge, D R; Pemberton, M N; Growcott, J W; Johnstone, D; Laud, P J; Foster, J 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 230 KB

Fit-for-purpose in veterinary drug resid

Fit-for-purpose in veterinary drug residue analysis: Development and validation of an LC-MS/MS method for the screening of thirty illicit drugs in bovine urine

✍ Marta Leporati; Pierluigi Capra; Paola Brizio; Valentina Ciccotelli; Maria Cesar 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 407 KB 👁 1 views

## Abstract A selective and sensitive method for screening 31 analytes (nine corticosteroids, eight β‐agonists, seven anabolic steroids, six promazines and zeranol) in bovine urine was validated according to 2002/657/EC guidelines. Upon optimization of sample treatment conditions, the extraction wa

Development and validation of a new mode

Development and validation of a new model of inflammation in the cat and selection of surrogate endpoints for testing anti-inflammatory drugs

✍ J. M. GIRAUDEL; A. DIQUELOU; P. LEES; P. L. TOUTAIN 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 258 KB

Critical re-evaluation of previous precl

Critical re-evaluation of previous preclinical strategies for the discovery and the development of new antiepileptic drugs

✍ W Löscher; I.E Leppik 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 62 KB